Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04877912 · ClinicalTrials.gov registry record
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
A clinical trial, sponsored by University of Chicago.
- Terminated
- Registry status
- 166
- Enrollment target
NCT04877912 is a clinical trial that was terminated before completion, run by University of Chicago. The registered enrollment target is 166 participants.
The verdict
NCT04877912 was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- 166 participants
- Enrollment target
Study Summary
The purpose of this study is to test an innovative MRI breast cancer screening method in women with mammographically dense breasts as well as other women with moderately increased cancer risk. MRI, combined with other methods of risk assessment, has potential to significantly improve sensitivity to cancer in dense breasts and detect cancer in all cases at a much earlier stage, with far fewer interval cancers than mammography. Previous tests of MRI sensitivity show that this screening could significantly increase the likelihood of detecting invasive cancers resulting in decreased mortality from breast cancer. Suspicious lesions will be defined by the clinical interpretation of the breast MRI images performed by the attending breast radiologists. Based on the radiologist determination that the MRI findings are suspicious (these findings include masses, non-mass enhancement and foci), suspicious lesions will be assigned a Bi-Rads code specifying whether additional work up or biopsy is necessary. These are Bi-Rads codes 0, 4 and 5. False positive diagnosis should be minimized as all attending physicians reading breast MRI at this institution are fellowship trained in breast imaging.
Interventions
- DIAGNOSTIC_TEST MRI Abbreviated Scan
- DIAGNOSTIC_TEST Abbreviated MRI Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2022-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04877912
The ClinicalTrials.gov registry entry for NCT04877912 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MRI Abbreviated Scan is the first listed.
NCT04877912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04877912 about?
NCT04877912 is a clinical study titled "Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening". The purpose of this study is to test an innovative MRI breast cancer screening method in women with mammographically dense breasts as well as other women with moderately increased cancer risk. MRI, combined with other methods of risk assessment, has potential to significantly improve sensitivity to ...
What is the current status of trial NCT04877912?
This trial is currently terminated. The enrollment target is 166 participants. The study started on 2017-06-01. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04877912?
The interventions under investigation include: MRI Abbreviated Scan (DIAGNOSTIC_TEST), Abbreviated MRI Scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04877912?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.